Jump Financial LLC Takes $8.55 Million Position in Tempus AI, Inc. $TEM

Key Points

• Jump Financial LLC has acquired a new position in Tempus AI, Inc., purchasing 177,135 shares valued at approximately $8.55 million.
• Major institutional investors, including ARK Investment Management and Vanguard Group, have significantly increased their holdings in Tempus AI, indicating strong interest in the stock.
• Tempus AI recently reported a quarterly revenue increase of 89.5% year-over-year, surpassing analysts' expectations with revenues of $314.64 million.

Jump Financial LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund purchased 177,135 shares of the company's stock, valued at approximately $8,545,000. Jump Financial LLC owned about 0.10% of Tempus AI as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cherry Tree Wealth Management LLC bought a new stake in shares of Tempus AI in the 1st quarter worth approximately $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI in the 1st quarter worth approximately $33,000. Continuum Advisory LLC bought a new stake in shares of Tempus AI in the 1st quarter worth approximately $39,000. Bartlett & CO. Wealth Management LLC raised its holdings in shares of Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares during the period. Finally, Nemes Rush Group LLC bought a new stake in shares of Tempus AI in the 1st quarter worth approximately $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Tempus AI Stock Performance

NASDAQ:TEM traded up $1.68 during trading hours on Thursday, reaching $74.91. 3,242,647 shares of the company's stock were exchanged, compared to its average volume of 12,494,339. The firm has a market capitalization of $13.01 billion, a price-to-earnings ratio of -62.95 and a beta of 4.98. The company has a 50-day moving average of $64.06 and a 200 day moving average of $59.37. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. During the same quarter last year, the firm posted ($6.86) EPS. The business's revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insiders Place Their Bets

In other Tempus AI news, EVP Andrew Polovin sold 5,398 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $402,960.70. Following the transaction, the executive vice president directly owned 132,056 shares of the company's stock, valued at $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Erik Phelps sold 3,664 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the transaction, the executive vice president directly owned 94,115 shares in the company, valued at approximately $7,025,684.75. The trade was a 3.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 776,451 shares of company stock valued at $53,022,688. 26.27% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. BTIG Research upped their target price on shares of Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday, August 20th. Bank of America upped their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research report on Friday, August 8th. Finally, Guggenheim upped their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and an average target price of $67.64.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.